Tasly unit invests $50M in Chinese diabetes play Genova

Genova Biotech Co. Ltd. (Changzhou, China) received a $50 million investment from an undisclosed subsidiary of Tasly Holdings Group Co. Ltd. (Shanghai:600535). According to Genova financial advisor China Renaissance, the investment is part of Genova’s series B round...